Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
grade A 159.11 1.58% 2.47
EW closed up 1.58 percent on Thursday, January 17, 2019, on 1.18 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Jan 31

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical EW trend table...

Date Alert Name Type % Chg
Jan 17 Cup with Handle Other 0.00%
Jan 17 Stochastic Reached Overbought Strength 0.00%
Jan 17 Multiple of Ten Bearish Other 0.00%
Jan 17 Inside Day Range Contraction 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 16 Cup with Handle Other 1.58%
Jan 16 Multiple of Ten Bearish Other 1.58%
Jan 16 Upper Bollinger Band Touch Strength 1.58%
Jan 15 Crossed Above 20 DMA Bullish -1.84%
Jan 15 Crossed Above 50 DMA Bullish -1.84%

Older signals for EW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
Is EW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 175.0
52 Week Low 121.4
Average Volume 1,348,524
200-Day Moving Average 146.6475
50-Day Moving Average 153.986
20-Day Moving Average 151.073
10-Day Moving Average 154.066
Average True Range 5.5297
ADX 16.7
+DI 27.9577
-DI 20.4318
Chandelier Exit (Long, 3 ATRs ) 146.2909
Chandelier Exit (Short, 3 ATRs ) 156.2291
Upper Bollinger Band 161.2464
Lower Bollinger Band 140.8996
Percent B (%b) 0.9
BandWidth 13.468191
MACD Line 0.8986
MACD Signal Line -0.2292
MACD Histogram 1.1277
Fundamentals Value
Market Cap 33.6 Billion
Num Shares 211 Million
EPS 3.30
Price-to-Earnings (P/E) Ratio 48.22
Price-to-Sales 6.75
Price-to-Book 7.42
PEG Ratio 1.70
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 165.73
Resistance 3 (R3) 165.43 162.92 164.62
Resistance 2 (R2) 162.92 161.24 163.07 164.25
Resistance 1 (R1) 161.02 160.20 161.97 161.32 163.89
Pivot Point 158.51 158.51 158.99 158.66 158.51
Support 1 (S1) 156.61 156.83 157.56 156.91 154.33
Support 2 (S2) 154.10 155.79 154.25 153.97
Support 3 (S3) 152.20 154.10 153.60
Support 4 (S4) 152.50